Severe clinical spectrum with high mortality in pediatric patients with COVID-19 and multisystem inflammatory syndrome

Imagem de Miniatura
Arquivos
art_PEREIRA_Severe_clinical_spectrum_with_high_mortality_in_pediatric_2020.PDF.pdf (195.59 KB)
Citações na Scopus
59
Tipo de produção
article
Data de publicação
2020
DOI
SciELO
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
HOSPITAL CLINICAS, UNIV SAO PAULO
Autores
Citação
CLINICS, v.75, article ID e2209, 7p, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
OBJECTIVES: To assess the outcomes of pediatric patients with laboratory-confirmed coronavirus disease (COVID-19) with or without multisystem inflammatory syndrome in children (MIS-C). METHODS: This cross-sectional study included 471 samples collected from 371 patients (age<18 years) suspected of having severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The study group comprised 66/371 (18%) laboratory-confirmed pediatric COVID-19 patients: 61 (92.5%) patients tested positive on real-time reverse transcription-polymerase chain reaction tests for SARS-CoV-2, and 5 (7.5%) patients tested positive on serological tests. MIS-C was diagnosed according to the criteria of the Center for Disease Control. RESULTS: MIS-C was diagnosed in 6/66 (9%) patients. The frequencies of diarrhea, vomiting, and/or abdominal pain (67% vs. 22%, p=0.034); pediatric SARS (67% vs. 13%, p=0.008); hypoxemia (83% vs. 23%, p=0.006); and arterial hypotension (50% vs. 3%, p=0.004) were significantly higher in patients with MIS-C than in those without MIS-C. The frequencies of C-reactive protein levels >50 mg/L (83% vs. 25%, p=0.008) and D-dimer levels >1000 ng/mL (100% vs. 40%, p=0.007) and the median D-dimer, troponin T, and ferritin levels (p < 0.05) were significantly higher in patients with MIS-C. The frequencies of pediatric intensive care unit admission (100% vs. 60%, p=0.003), mechanical ventilation (83% vs. 7%, p < 0.001), vasoactive agent use (83% vs. 3%, p <0.001), shock (83% vs. 5%, p<0.001), cardiac abnormalities (100% vs. 2%, p <0.001), and death (67% vs. 3%, p < 0.001) were also significantly higher in patients with MIS-C. Similarly, the frequencies of oxygen therapy (100% vs. 33%, p=0.003), intravenous immunoglobulin therapy (67% vs. 2%, p < 0.001), aspirin therapy (50% vs. 0%, p < 0.001), and current acute renal replacement therapy (50% vs. 2%, p=0.002) were also significantly higher in patients with MIS-C. Logistic regression analysis showed that the presence of MIS-C was significantly associated with gastrointestinal manifestations [odds ratio (OR)=10.98; 95%CI (95% confidence interval)=1.20-100.86; p=0.034] and hypoxemia [OR=16.85; 95%CI=1.34-211.80; p=0.029]. Further univariate analysis showed a positive association between MIS-C and death [OR=58.00; 95%CI=6.39526.79; p <0 .0001]. CONCLUSIONS: Pediatric patients with laboratory-confirmed COVID-19 with MIS-C had a severe clinical spectrum with a high mortality rate. Our study emphasizes the importance of investigating MIS-C in pediatric patients with COVID-19 presenting with gastrointestinal involvement and hypoxemia.
Palavras-chave
COVID-19, Children, Adolescent, Outcome, Immunosuppression, Multisystem Inflammatory Syndrome
URI
https://observatorio.fm.usp.br/handle/OPI/37839
Referências
  1. Almeida FJ, 2020, PEDIATR INFECT DIS J, V39, pE161, DOI 10.1097/INF.0000000000002737
  2. Alveno RA, 2018, J PEDIAT-BRAZIL, V94, P539, DOI 10.1016/j.jped.2017.07.014
  3. Andre N, 2020, PEDIATR BLOOD CANCER, V67, DOI 10.1002/pbc.28392
  4. [Anonymous], INF HEALTHC PROV MUL
  5. Beavis KG, 2020, J CLIN VIROL, V129, DOI 10.1016/j.jcv.2020.104468
  6. Bialek S, 2020, MMWR-MORBID MORTAL W, V69, P422, DOI 10.15585/mmwr.mm6914e4
  7. Passone CGB, 2020, REV PAUL PEDIATR, V38, DOI 10.1590/1984-0462/2020/38/2018101
  8. Capone CA, 2020, J PEDIATR-US, V224, P141, DOI [10.1018/j.jpeds.2020.08.044, 10.1016/j.jpeds.2020.06.044]
  9. Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045
  10. Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702
  11. Dufort EM, 2020, NEW ENGL J MED, V383, P347, DOI 10.1056/NEJMoa2021756
  12. European Centre for Disease Prevention and Control, 2020, PAED INFL MULT SYNDR
  13. Feldstein LR, 2020, NEW ENGL J MED, V383, P334, DOI 10.1056/NEJMoa2021680
  14. Garazzino S, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.18.2000600
  15. Hrusak O, 2020, EUR J CANCER, V132, P11, DOI 10.1016/j.ejca.2020.03.021
  16. Kaushik S, 2020, J PEDIATR-US, V224, P24, DOI 10.1016/j.jpeds.2020.06.045
  17. Livingston Edward, 2020, JAMA, V323, P1335, DOI 10.1001/jama.2020.4344
  18. Ludvigsson JF, 2020, ACTA PAEDIATR, V109, P1088, DOI 10.1111/apa.15270
  19. Miethke-Morais A, 2020, CLINICS, V75, DOI 10.6061/clinics/2020/e2100
  20. Safadi MAP, 2021, REV PAUL PEDIATR, V39, DOI 10.1590/1984-0462/2020/38/2020192
  21. Palmeira P, 2020, CLINICS, V75, DOI 10.6061/clinics/2020/e1947
  22. Ramcharan T, 2020, PEDIATR CARDIOL, DOI 10.1007/s00246-020-02391-2
  23. Ramos GF, 2019, J PEDIAT-BRAZIL, V95, P667, DOI 10.1016/j.jped.2018.06.006
  24. Riphagen S, 2020, LANCET, V395, P1607, DOI [10.1016/50140-6736(20)31094-1, 10.1016/S0140-6736(20)31094-1]
  25. Shekerdemian LS, 2020, JAMA PEDIATR, V174, P868, DOI 10.1001/jamapediatrics.2020.1948
  26. Shen B, 2020, AM J TRANSL RES, V12, P1348
  27. Silva CA, 2020, CLINICS, V75, DOI 10.6061/clinics/2020/e1931
  28. Surveillances V., 2020, ZHONGHUA LIU XING BI, V2, P113, DOI 10.3760/CMA.J.ISSN.0254-6450.2020.02.003
  29. Tang Yi-Wei, 2020, J Clin Microbiol, V58, DOI 10.1128/JCM.00512-20
  30. Verdoni L, 2020, LANCET, V395, P1771, DOI 10.1016/S0140-6736(20)31103-X
  31. World Health Organization, COR DIS COVID 19 SIT
  32. Zhao Juanjuan, 2020, Clin Infect Dis, DOI 10.1093/cid/ciaa344

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPE
Artigos e Materiais de Revistas Científicas - COVID-19
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/ICr
Artigos e Materiais de Revistas Científicas - LIM/03
Artigos e Materiais de Revistas Científicas - LIM/05
Carregar mais